Primary Care for Women with Intellectual Disabilities

Menstrual Disorders

For most women in the general population, menstrual disorders include the management of dysmenorrhea, amenorrhea, and menorrhagia, which are most often related to anovulatory cycles but also to uterine disorders such as fibroids. For women with ID, another issue can be added to this category: the inability to manage menstrual hygiene and the risk of self-injurious behaviors that can arise around menstruation. These issues have prompted, in some cases, the inducement of elective or therapeutic amenorrhea.

Reasons for therapeutic amenorrhea may include contraception (especially if the patient is taking teratogenic antiepileptic drugs), quality of life (if the patient is frightened by or unable to attend hygienically to her menses), or the treatment of menorrhagia or dysmenorrhea. A case-control study in Scandinavia compared women with and without ID who were patients in a gynecological practice. “Typical” women were much more likely to list pregnancy, abortion, or dilation and curettage as their reason for the visit; women with ID were more likely to be there for therapeutic amenorrhea.⁹ More than half (67%) of the women with ID in this study sought therapeutic amenorrhea at some point in their lives. More recent studies discuss this therapy in light of caregivers’ ethical responsibilities to the women in their care and have advocated the “least restrictive option.” Least restriction involves a less invasive option that is more likely to be reversible and preserve the patient's options in terms of fertility. Least restriction implies using medications or progestin intrauterine device over endometrial ablation or surgery.¹⁰ In fact, one prospective cohort study observed that of 107 women with ID, only 2 eventually required surgical management of their menstrual/contraceptive issues.¹¹ In recent years physicians have attempted to manage women with ID respectfully with regard to their potential reproductive rights, choosing less restrictive, more reversible options for contraception and therapeutic amenorrhea.

Researchers note that primary care physicians have not focused on menstrual issues for women with ID—one survey of community-dwelling women noted that 40% of the women surveyed were not asked about their gynecological needs by their primary care physician.¹² Another researcher investigated the commonly held belief that women with Down syndrome either have amenorrhea or are infertile. In this survey of an admittedly small number of women with Down syndrome and age-matched controls, the age at menarche, cycle length, and duration of menses were indistinguishable between the 2 groups, indicating that women with Down syndrome are likely ovulating at comparable rates to women without Down syndrome.¹³

The Australian Society of Pediatric and Adolescent Gynecology published a consensus statement on the clinical management of menstrual issues in women with ID in 2003.¹⁴ The statement advocates a stepwise management to menstrual difficulties in women with ID, starting with the least invasive options and progressing to therapies that require more complex forms of consent.

Cervical Cancer Screening

Many primary care physicians question the indication for yearly Papanicolaou tests in adult women with ID given the difficulties of the examination. For many women with ID, the experience of the gynecological examination is painful, frightening, may call to mind past episodes of abuse, and may result in increased fear about visiting the doctor's office—all undesired outcomes for a physician who has worked hard to gain a patient's trust. Only recently has there been sufficient evidence suggesting that it is safe to omit the annual Papanicolaou test, although the numbers of women with ID actually being screened is approximately 15%.¹⁵ Two cohort studies in the past decade examined the largest (n > 300) groups of women with ID to date residing in institutional settings and found that the number of abnormal Papanicolaou smears was extremely low,^16,17 although it should be noted that the sample was biased toward lower-risk (institutionalized) women. As more women grow up and socialize in their communities, their opportunities for consensual sexual activities increase. Based on our review of the literature, we recommend individualizing the interval for screening to each patient's risk,¹⁸ keeping in mind that women with ID may be less able to accurately relate their sexual history. In such cases, details about the patient's environment and known history may be helpful. For example, a woman living in a highly supervised, single-sex environment since childhood is unlikely to be sexually active and might be a good candidate for less-frequent screening and/or human papillomavirus (HPV) screening (see below).

Techniques for performing the examination in women with both physical¹⁹ and intellectual disabilities exist for those women considered at sufficient risk for regular exams. For women with ID, several factors have been found to be helpful, including prolonged preparation for the examination, communication with the provider, explanation appropriate to the patient's level of understanding, and support.²⁰ Protocols have been developed which focus on stepwise relaxation²¹ and deep breathing exercises; using a small, warmed speculum may also be helpful. In some cases, it may be necessary to premedicate with benzodiazepines²² or use conscious sedation²³ to complete the gynecological examination. Currently, no consensus exists as to which methods are best tolerated and least risky, and different methods may be appropriate for different women.

Although the feasibility and accuracy of HPV screening compared with traditional cytology for the detection of cervical cancer²⁴ has not been studied in women with ID, it may prove to be an alternative form of less-frequent screening for these lower-risk women. The American Cancer Society (ACS) and American College of Obstetrics & Gynecology (ACOG) recommend less frequent screening (every 3 years) for women with negative HPV screening and a normal Papanicolaou smear²⁵; this recommendation is appropriate for many women with ID. Finally, it should be noted that there may be reasons other than cervical cancer screening to do a gynecological examination—for example, the evaluation of pelvic pain or uterine/adnexal pathology. If cervical cancer screening is not a priority (for example, in women who have never been sexually active), then we recommend considering bimanual examination or pelvic ultrasound instead of speculum exams to evaluate potential gynecological problems, as they may be better tolerated. If the clinician needs to screen the patient for sexually transmitted infections other than HPV, urine testing provides a less invasive way to accomplish this²⁶ and is likely to be more acceptable for the patient.

Contraception

There are many reasons to consider contraception for women with ID. Women with ID may not desire or may not be good candidates for pregnancy if they chronically take teratogenic medications (such as some antiepileptic drugs). Caretakers may worry about the ability of a woman with ID to understand pregnancy, to care for herself during a pregnancy, or to care for a child. Investigators in Brussels²⁷ surveyed nearly 400 women with ID to determine what method, if any, they used for contraception and what social and medical factors influenced their choice of method. The majority of women surveyed were using contraception (59%) with the most common method being surgical sterilization (22%), followed by oral contraceptives and Depo-Provera (each 18%). Factors influencing their choice of method were almost entirely environmental and focused on the setting in which they lived (single-sex or coed, with or without rules allowing sexual intercourse and/or requiring contraception). The results of this study suggest that at least in Brussels, the contraception decisions of women with ID may be made based on the rules of the setting in which they live. A recent study of the use of antiepileptic drugs in women with ID²⁸ noted that some of these drugs (eg, carbamazepine, phenytoin, and valproate) were teratogenic and interfered with the efficacy of oral contraceptives, making these medications an important element of the medical history to consider when treating women with ID.

The question of whether someone with ID would make a “good parent” can be quite subjective and has been the focus of ethical discussions for years. The current foundations of ethical thinking regarding contraception for women with ID are summarized at the end of this article.

The Australian Society of Pediatric and Adolescent Gynecology consensus statement in regard to menstrual issues¹⁴ and a special issue of the Contraception Report²⁹ describe clinical guidelines for contraceptive management, social and psychological implications of contraceptive counseling, and the ethical issues surrounding birth control for women with ID.

Breast Cancer Screening

Ethnic, racial, and socioeconomic disparities in breast cancer screening present major challenges to the American health care system. Disparities in screening for women with physical^30–32 and intellectual disabilities also exist and have received less attention. Only approximately one-third of eligible women with ID were screened for breast cancer in 2 regional samples from England³³ and Australia.³⁴ In the Australian study, women were less likely to be screened if they were unmarried, lived in an urban setting, had severe ID, or had concomitant physical disabilities. Australian investigators who interviewed caregivers about ways to increase mammography in women with ID concluded that many barriers to mammography seemed insurmountable (especially physical barriers for patients with comorbid physical disabilities). They suggested alternative methods of screening (such as clinical breast examination)—methods which lack sufficient evidence for their use as screening tools in the general population.³⁵

Rates of breast cancer in women with ID reported in 2 large cohort studies are the same as or lower than the general population.^36,37 However, women with ID are living longer and because the risk of breast cancer rises with each decade of life,³⁸ the rates of breast cancer in women with ID will probably rise. An interesting note is that women with Down syndrome seem to have extremely low rates of breast cancer,³⁹ so low that some have advocated simply not screening them, as the risk conferred by the radiation of mammography is probably higher.⁴⁰

There is a need for further research on breast cancer screening for women with ID in the United States, focusing on cancer incidence, factors associated with underuse of mammography for women with ID, and guidelines for determining who should and should not be screened. There is some current controversy about clinical management (mammography versus clinical breast examination or ultrasound) as we await better evidence-based guidelines, but several consensus statements^41,42 and a prior review on screening¹⁸ advocate following the same guidelines as for the general population.

Osteoporosis

The increased prevalence of osteoporosis among all people with intellectual disabilities is well-documented.^43–48 Relatively fewer studies have investigated the risk factors for low bone density within the population of adults with ID—for example, epilepsy⁴⁹ or Down syndrome.⁵⁰ Adults with ID who live in group homes have high facture rates compared with the general population.⁵¹ Two researchers reported the specific risk factors associated with the highest rates of osteoporosis and osteopenia among adults with ID.^52,53 Both studies conclude that nonambulation and anticonvulsant use are important factors associated with low bone density, although the smaller study⁵³ commented that the anticonvulsant risk was highest in postmenopausal women. Down syndrome and low peak bone mass were listed as important risk factors in one review,⁵² whereas ethnicity was felt to be important in the smaller study, with Hispanic and Caucasian women at relatively higher risk.

To date, no clinical trials have determined the best practice for screening adults with ID for osteoporosis. However, early screening for osteoporosis (see Table 2), especially among patients who are nonambulatory or taking anticonvulsants, is advocated.^{18,41,42,54,55}